Connect with us

Spread & Containment

“The End Of Abenomics” – Japan’s Struggling Prime Minister Suga Unexpectedly Steps Down

"The End Of Abenomics" – Japan’s Struggling Prime Minister Suga Unexpectedly Steps Down

Japan’s original doom loop – rotating prime ministers who stay on the job for about a year only to resign and leave the country in even worse shape -…

Published

3 years ago

on

"The End Of Abenomics" - Japan's Struggling Prime Minister Suga Unexpectedly Steps Down

Japan's original doom loop - rotating prime ministers who stay on the job for about a year only to resign and leave the country in even worse shape - is back.

Less than a year after he was appointed to replace Shinzo Abe, Japanese Prime Minister Yoshihide Suga said in a surprise move on Friday he would step down, setting the stage for a new premier after a one-year tenure marred by an dismal and unpopular Covid response and sinking public support. Suga, who took over after Shinzo Abe - who resigned last September for the second time as prime minister citing ill health although this time it wasn't diarrhea, unlike the reason cited for his first departure - had seen his approval ratings drop below 30% as the nation struggled with its worst wave of covid infections ahead of a general election this year (despite mandatory masks).

"I want to focus on coronavirus response, so I told the LDP executive meeting that I've decided not to run in the party leadership race," Suga told reporters. "I judged that I cannot juggle both and I should concentrate on either of them."

Suga did not capitalize on his last major "achievement" - hosting the Olympics, which were postponed months before he took office as coronavirus cases surged, and which proved to be highly unpopular with the population, merely saddling Japan with even more debt.

His decision not to seek reelection as ruling Liberal Democratic Party (LDP) president this month means the party will choose a new leader, who will become prime minister.

While there was no clear frontrunner, the popular minister in charge of Japan's vaccination rollout, Taro Kono, intends to run, broadcaster TBS said on Friday without citing sources. Former foreign minister Fumio Kishida has already thrown his hat in the ring. Before Abe's record eight-year tenure, the country had gone through six prime ministers in as many years, including Abe's own troubled first one-year term.

Succession

Declaring himself a contender for Japan's next leader, Kishida, a soft-spoken Hiroshima lawmaker, on Thursday criticised Suga's coronavirus response and urged a stimulus package to combat the pandemic.

"Kishida is the top runner for the time being but that doesn't mean his victory is assured," said Koichi Nakano, political science professor at Sophia University. Nakano said Kono, Suga's administrative reform minister, could run if he gets the backing of his faction leader in the party, Finance Minister Taro Aso.

Former defense minister Shigeru Ishiba, also popular with the public as a potential premier, said he was ready to run if the conditions and environment are right. He was a rare LDP critic of Abe during his time as prime minister.

Kono has led Japan's rocky inoculation drive but remains high on the list of lawmakers voters want to see succeed Suga. Kono did not deny media reports but stopped short of declaring his candidacy, telling reporters he wanted to carefully consult with party colleagues first.

A former foreign and defense minister, Kono, 58, is popular with younger voters after building support through Twitter, where he has 2.3 million followers - a rarity in Japanese politics dominated by men who are older and less social media-savvy.

Abe's stance will also be closely watched given his influence inside the two largest factions of the LDP and among conservative MPs, experts say.

LDP Fate

The LDP-led coalition is not expected to lose its majority in the lower house, but forecasts suggest the party could lose the majority that it holds on its own, an outcome that would weaken whoever leads the party next. "Stock prices are rising based on a view that the chance of LDP's defeat in the general election has diminished because anyone other than Suga will be able to regain popularity," said senior economist at Daiwa Securities Toru Suehiro.

Suga's image as a shrewd political operator capable of pushing through reforms and taking on the stodgy bureaucracy propelled his support to 74% when he took office.

He initially won applause for populist promises such as lower mobile phone rates and insurance for fertility treatments. But removing scholars critical of the government from an advisory panel and compromising with a junior coalition partner on policy for healthcare costs for the elderly drew criticism.

His delay in halting a domestic travel program - which experts say may have helped spread coronavirus around Japan - hit hard, while the public grew weary of states of emergency that hurt businesses.

Market Reaction

Tokyo stocks jumped on news of Suga's decision, a move that investors say could serve as an inflection point for local stocks, with the benchmark Nikkei rising 2% and the broader Topix hitting its highest levels since 1991. The nation’s equities have been largely range-bound for months amid uncertainty over the upcoming election and concern over the latest wave of coronavirus cases, as Japan’s vaccination campaign and reopening lagged those of the U.S. and Europe.  While it’s not unclear who will replace Suga, many said that regardless of who becomes the next prime minister, a large economic stimulus is likely. Others cheered the possibility of political stability, as prospects for a more comprehensive victory for the ruling Liberal Democratic Party in the upcoming election increase. 

At the same time, Japanese government bonds fell, led by super-long maturities, as traders weighed the risk of more stimulus spending with a change in the nation’s leadership. The yen weakened after stocks rallied. JGB futures ended day session down 0.08 at 151.98 with the benchmark 10- year yield rising 0.5bp to 0.035, the highest since Aug. 11. Yields on maturities above 10 years also climbed, with that on 20-year notes up 1bp to 0.415%

The market reaction to Suga reflects wariness about more debt issuance next year as his successor is likely to resort to fiscal stimulus to limit the damage from the outbreak, said Naoya Oshikubo, a senior economist at Sumitomo Mitsui Trust Asset Management in Tokyo

Suga's abrupt resignation ended a rollercoaster week in which Suga pulled out all the stops to save his job, including suggestions he would sack his long-term party ally, as well as plans to dissolve parliament and reshuffle party executive and his cabinet. He is expected to stay on until his successor is chosen in the party election slated for Sept. 29. The winner, assured of being premier due to the LDP's majority in the lower house of parliament, must call the general election by Nov. 28.

In response to the resignation news, views differed from the bullish, as this one from BBG's Yoshiaki Nohara...

Japanese Prime Minister Suga’s decision to step aside is only going to intensify calls for a big stimulus package. Whoever comes to power next will want to woo a pandemic-frustrated public, and the promise for extra dollops of cash will be welcome news for Tokyo’s equity bulls. The economy has managed to avoid a double-dip recession, there are signs that companies are looking past the virus and there was plenty left over from last year’s stimulus spending plan. But a national election is due soon, and so politics, not economics, will require another round of spending

... to the skeptical as this one from Bloomberg's Gearoid Reidy:

The shock effective resignation of PM Yoshihide Suga, who most expected to lead the ruling LDP into a general election this fall, is pleasing equity investors --but caution is warranted. While Suga was deeply unpopular and widely criticized for his handling of the pandemic, there are dangers here for markets. Suga, whose premiership represented a continuation of Shinzo Abe’s exit, could effectively mark the end of nearly a decade of Abenomics. And while the lure of Fumio Kishida’s promise of “tens of trillions of yen” of spending to control the pandemic may sound appealing to investors, don’t forget what Japanese politics was like before the Abe-Suga era. The biggest fear of many analysts is that a premature Suga exit could represent a return to the revolving-door premierships of the late 2000s, when successive prime ministers, each with only fractional control of the ruling party, lasted only a year. That wasn’t enough time to put any of their pet economic projects into action, and contributed to leaving Japan’s economy and market languishing. While the Topix is rallying today, a return to that era would not be good news for stocks.

Here’s what other analysts across asset classes are saying:

Mitsubishi UFJ Morgan Stanley Securities (Norihiro Fujito)

  • “If the LDP were to win the general election soundly, the rally in Japanese stocks could continue. Foreign investors could revisit Japanese equities as valuations have been very cheap to begin with. The Nikkei 225 could climb back up to 30,000.”
  • “Investors and consumers will expect policies under a fresh new leadership, and people assume that the LDP won’t lose so badly in the upcoming general election.”
  • “Investors and consumers are expecting some ground-breaking stimulus, regardless of who might take over.”

Shinkin Asset (Naoki Fujiwara)

  • “This is a plus for equities -- with a new person leading, there will be expectations over policy steps.” Suga’s decision to resign might be a “turning point” for local equities.
  • “The cloud may be gradually lifting for Japanese equities in terms of the overall environment.”
  • “The virus situation is calming down, while we could see political risks easing from here, compared to before.”

T&D Asset (Hiroshi Namioka)

  • Suga’s decision could help Japanese stocks “get out of a range.”
  • His low approval rating has weighed on Japanese equities, and “for the stock market, it could be important to see the LDP regain its approval rating and not lose a majority during the general election.”

JP Morgan Asset (Shogo Maekawa)

  • With Suga’s resignation, the LDP can head for the general election with a “slightly better support rate.”
  • The risk that the ruling party might see a big loss of seats in the election, which would destabilize the administration, has been reduced. “Lowering those risks is something that local stocks would welcome.”
  • The move will also boost expectations over economy- boosting measures, as well as progress on steps to get more people vaccinated and gradually prepping for “normalization” of the economy.

Asymmetric Advisors (Amir Anvarzadeh)

  • “Logic prevails as LDP was bound to lose many seats in the Lower House if Suga continued after his monumental failure on betting on Olympics and acting too slow on vaccines.”
  • “Suga’s departure will be viewed as positively, at least for now given his shortcomings. Question is will LDP yield to the will of the nation and allow” the popular Taro Kono to become prime minister

Gaitame.com Research Institute (Takuya Kanda)

  • Yen may stay pressured despite the news; regardless of who becomes LDP leader and thus next premier, there won’t likely be a major shift in Japan’s economic and monetary policy
  • Markets have seen Suga as a reason for falling support rating for the government and the ruling Liberal Democratic Party, so his departure probably could give a sense of relief; this may add to global risk-on
  • Currency market players aren’t likely to use Japanese politics to make bets on yen
  • As long as stocks are rising, expectations for united and stable LDP will be a yen weakness factor

Mitsubishi UFJ Morgan Stanley Securities (Naomi Muguruma)

  • “The risk of a bigger economic stimulus package may be weighing on Japan’s bonds.”
  • “A new leader for the ruling Liberal Democratic Party would face a lower house election soon and that may pressure the new leader to boost stimulus, which is positive for stocks but a source of concern for bonds.”

Oanda (Jeffrey Halley)  

  • Given Nikkei 225’s rally, “it is clear that domestically they feel that Suga’s resignation will add more political stability ahead of the October election, and will prompt more stimulus from either the government or the BOJ, or both.”
  • “Given the complete debacle of Japan’s Covid-19 response, it seemed inevitable that he had become a political liability, although I expected him to go after, and not before the election.”
  • “Of course, who PM Suga will be replaced by will be the critical development. Will the LDP go back to the future and insert another ‘aged establishment’ leader, or will they seize the opportunity to reinvigorate the leadership.”
  • “I know which my money is on, and on that basis, I do not see the rally of today continuing with the same momentum, although I would love to be pleasantly surprised and proven wrong.”
Tyler Durden Fri, 09/03/2021 - 06:59

Read More

Related Topics:
Continue Reading

Government

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19…

Published

4 hours ago

on

March 11, 2024

By

Fauci Deputy Warned Him Against Vaccine Mandates: Email

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Mandating COVID-19 vaccination was a mistake due to ethical and other concerns, a top government doctor warned Dr. Anthony Fauci after Dr. Fauci promoted mass vaccination.

“Coercing or forcing people to take a vaccine can have negative consequences from a biological, sociological, psychological, economical, and ethical standpoint and is not worth the cost even if the vaccine is 100% safe,” Dr. Matthew Memoli, director of the Laboratory of Infectious Diseases clinical studies unit at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), told Dr. Fauci in an email.

“A more prudent approach that considers these issues would be to focus our efforts on those at high risk of severe disease and death, such as the elderly and obese, and do not push vaccination on the young and healthy any further.”

Dr. Anthony Fauci, ex-director of the National Institute of Allergy and Infectious Diseases (NIAID. in Washington on Jan. 8, 2024. (Madalina Vasiliu/The Epoch Times)

Employing that strategy would help prevent loss of public trust and political capital, Dr. Memoli said.

The email was sent on July 30, 2021, after Dr. Fauci, director of the NIAID, claimed that communities would be safer if more people received one of the COVID-19 vaccines and that mass vaccination would lead to the end of the COVID-19 pandemic.

“We’re on a really good track now to really crush this outbreak, and the more people we get vaccinated, the more assuredness that we’re going to have that we’re going to be able to do that,” Dr. Fauci said on CNN the month prior.

Dr. Memoli, who has studied influenza vaccination for years, disagreed, telling Dr. Fauci that research in the field has indicated yearly shots sometimes drive the evolution of influenza.

Vaccinating people who have not been infected with COVID-19, he said, could potentially impact the evolution of the virus that causes COVID-19 in unexpected ways.

“At best what we are doing with mandated mass vaccination does nothing and the variants emerge evading immunity anyway as they would have without the vaccine,” Dr. Memoli wrote. “At worst it drives evolution of the virus in a way that is different from nature and possibly detrimental, prolonging the pandemic or causing more morbidity and mortality than it should.”

The vaccination strategy was flawed because it relied on a single antigen, introducing immunity that only lasted for a certain period of time, Dr. Memoli said. When the immunity weakened, the virus was given an opportunity to evolve.

Some other experts, including virologist Geert Vanden Bossche, have offered similar views. Others in the scientific community, such as U.S. Centers for Disease Control and Prevention scientists, say vaccination prevents virus evolution, though the agency has acknowledged it doesn’t have records supporting its position.

Other Messages

Dr. Memoli sent the email to Dr. Fauci and two other top NIAID officials, Drs. Hugh Auchincloss and Clifford Lane. The message was first reported by the Wall Street Journal, though the publication did not publish the message. The Epoch Times obtained the email and 199 other pages of Dr. Memoli’s emails through a Freedom of Information Act request. There were no indications that Dr. Fauci ever responded to Dr. Memoli.

Later in 2021, the NIAID’s parent agency, the U.S. National Institutes of Health (NIH), and all other federal government agencies began requiring COVID-19 vaccination, under direction from President Joe Biden.

In other messages, Dr. Memoli said the mandates were unethical and that he was hopeful legal cases brought against the mandates would ultimately let people “make their own healthcare decisions.”

“I am certainly doing everything in my power to influence that,” he wrote on Nov. 2, 2021, to an unknown recipient. Dr. Memoli also disclosed that both he and his wife had applied for exemptions from the mandates imposed by the NIH and his wife’s employer. While her request had been granted, his had not as of yet, Dr. Memoli said. It’s not clear if it ever was.

According to Dr. Memoli, officials had not gone over the bioethics of the mandates. He wrote to the NIH’s Department of Bioethics, pointing out that the protection from the vaccines waned over time, that the shots can cause serious health issues such as myocarditis, or heart inflammation, and that vaccinated people were just as likely to spread COVID-19 as unvaccinated people.

He cited multiple studies in his emails, including one that found a resurgence of COVID-19 cases in a California health care system despite a high rate of vaccination and another that showed transmission rates were similar among the vaccinated and unvaccinated.

Dr. Memoli said he was “particularly interested in the bioethics of a mandate when the vaccine doesn’t have the ability to stop spread of the disease, which is the purpose of the mandate.”

The message led to Dr. Memoli speaking during an NIH event in December 2021, several weeks after he went public with his concerns about mandating vaccines.

“Vaccine mandates should be rare and considered only with a strong justification,” Dr. Memoli said in the debate. He suggested that the justification was not there for COVID-19 vaccines, given their fleeting effectiveness.

Julie Ledgerwood, another NIAID official who also spoke at the event, said that the vaccines were highly effective and that the side effects that had been detected were not significant. She did acknowledge that vaccinated people needed boosters after a period of time.

The NIH, and many other government agencies, removed their mandates in 2023 with the end of the COVID-19 public health emergency.

A request for comment from Dr. Fauci was not returned. Dr. Memoli told The Epoch Times in an email he was “happy to answer any questions you have” but that he needed clearance from the NIAID’s media office. That office then refused to give clearance.

Dr. Jay Bhattacharya, a professor of health policy at Stanford University, said that Dr. Memoli showed bravery when he warned Dr. Fauci against mandates.

“Those mandates have done more to demolish public trust in public health than any single action by public health officials in my professional career, including diminishing public trust in all vaccines.” Dr. Bhattacharya, a frequent critic of the U.S. response to COVID-19, told The Epoch Times via email. “It was risky for Dr. Memoli to speak publicly since he works at the NIH, and the culture of the NIH punishes those who cross powerful scientific bureaucrats like Dr. Fauci or his former boss, Dr. Francis Collins.”

Tyler Durden Mon, 03/11/2024 - 17:40

Read More

Continue Reading

Government

Trump “Clearly Hasn’t Learned From His COVID-Era Mistakes”, RFK Jr. Says

Trump "Clearly Hasn’t Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President…

Published

4 hours ago

on

March 11, 2024

By

Trump "Clearly Hasn't Learned From His COVID-Era Mistakes", RFK Jr. Says

Authored by Jeff Louderback via The Epoch Times (emphasis ours),

President Joe Biden claimed that COVID vaccines are now helping cancer patients during his State of the Union address on March 7, but it was a response on Truth Social from former President Donald Trump that drew the ire of independent presidential candidate Robert F. Kennedy Jr.

Robert F. Kennedy Jr. holds a voter rally in Grand Rapids, Mich., on Feb. 10, 2024. (Mitch Ranger for The Epoch Times)

During the address, President Biden said: “The pandemic no longer controls our lives. The vaccines that saved us from COVID are now being used to help beat cancer, turning setback into comeback. That’s what America does.”

President Trump wrote: “The Pandemic no longer controls our lives. The VACCINES that saved us from COVID are now being used to help beat cancer—turning setback into comeback. YOU’RE WELCOME JOE. NINE-MONTH APPROVAL TIME VS. 12 YEARS THAT IT WOULD HAVE TAKEN YOU.”

An outspoken critic of President Trump’s COVID response, and the Operation Warp Speed program that escalated the availability of COVID vaccines, Mr. Kennedy said on X, formerly known as Twitter, that “Donald Trump clearly hasn’t learned from his COVID-era mistakes.”

“He fails to recognize how ineffective his warp speed vaccine is as the ninth shot is being recommended to seniors. Even more troubling is the documented harm being caused by the shot to so many innocent children and adults who are suffering myocarditis, pericarditis, and brain inflammation,” Mr. Kennedy remarked.

“This has been confirmed by a CDC-funded study of 99 million people. Instead of bragging about its speedy approval, we should be honestly and transparently debating the abundant evidence that this vaccine may have caused more harm than good.

“I look forward to debating both Trump and Biden on Sept. 16 in San Marcos, Texas.”

Mr. Kennedy announced in April 2023 that he would challenge President Biden for the 2024 Democratic Party presidential nomination before declaring his run as an independent last October, claiming that the Democrat National Committee was “rigging the primary.”

Since the early stages of his campaign, Mr. Kennedy has generated more support than pundits expected from conservatives, moderates, and independents resulting in speculation that he could take votes away from President Trump.

Many Republicans continue to seek a reckoning over the government-imposed pandemic lockdowns and vaccine mandates.

President Trump’s defense of Operation Warp Speed, the program he rolled out in May 2020 to spur the development and distribution of COVID-19 vaccines amid the pandemic, remains a sticking point for some of his supporters.

Vice President Mike Pence (L) and President Donald Trump deliver an update on Operation Warp Speed in the Rose Garden of the White House in Washington on Nov. 13, 2020. (Mandel Ngan/AFP via Getty Images)

Operation Warp Speed featured a partnership between the government, the military, and the private sector, with the government paying for millions of vaccine doses to be produced.

President Trump released a statement in March 2021 saying: “I hope everyone remembers when they’re getting the COVID-19 Vaccine, that if I wasn’t President, you wouldn’t be getting that beautiful ‘shot’ for 5 years, at best, and probably wouldn’t be getting it at all. I hope everyone remembers!”

President Trump said about the COVID-19 vaccine in an interview on Fox News in March 2021: “It works incredibly well. Ninety-five percent, maybe even more than that. I would recommend it, and I would recommend it to a lot of people that don’t want to get it and a lot of those people voted for me, frankly.

“But again, we have our freedoms and we have to live by that and I agree with that also. But it’s a great vaccine, it’s a safe vaccine, and it’s something that works.”

On many occasions, President Trump has said that he is not in favor of vaccine mandates.

An environmental attorney, Mr. Kennedy founded Children’s Health Defense, a nonprofit that aims to end childhood health epidemics by promoting vaccine safeguards, among other initiatives.

Last year, Mr. Kennedy told podcaster Joe Rogan that ivermectin was suppressed by the FDA so that the COVID-19 vaccines could be granted emergency use authorization.

He has criticized Big Pharma, vaccine safety, and government mandates for years.

Since launching his presidential campaign, Mr. Kennedy has made his stances on the COVID-19 vaccines, and vaccines in general, a frequent talking point.

“I would argue that the science is very clear right now that they [vaccines] caused a lot more problems than they averted,” Mr. Kennedy said on Piers Morgan Uncensored last April.

“And if you look at the countries that did not vaccinate, they had the lowest death rates, they had the lowest COVID and infection rates.”

Additional data show a “direct correlation” between excess deaths and high vaccination rates in developed countries, he said.

President Trump and Mr. Kennedy have similar views on topics like protecting the U.S.-Mexico border and ending the Russia-Ukraine war.

COVID-19 is the topic where Mr. Kennedy and President Trump seem to differ the most.

Former President Donald Trump intended to “drain the swamp” when he took office in 2017, but he was “intimidated by bureaucrats” at federal agencies and did not accomplish that objective, Mr. Kennedy said on Feb. 5.

Speaking at a voter rally in Tucson, where he collected signatures to get on the Arizona ballot, the independent presidential candidate said President Trump was “earnest” when he vowed to “drain the swamp,” but it was “business as usual” during his term.

John Bolton, who President Trump appointed as a national security adviser, is “the template for a swamp creature,” Mr. Kennedy said.

Scott Gottlieb, who President Trump named to run the FDA, “was Pfizer’s business partner” and eventually returned to Pfizer, Mr. Kennedy said.

Mr. Kennedy said that President Trump had more lobbyists running federal agencies than any president in U.S. history.

“You can’t reform them when you’ve got the swamp creatures running them, and I’m not going to do that. I’m going to do something different,” Mr. Kennedy said.

During the COVID-19 pandemic, President Trump “did not ask the questions that he should have,” he believes.

President Trump “knew that lockdowns were wrong” and then “agreed to lockdowns,” Mr. Kennedy said.

He also “knew that hydroxychloroquine worked, he said it,” Mr. Kennedy explained, adding that he was eventually “rolled over” by Dr. Anthony Fauci and his advisers.

President Donald Trump greets the crowd before he leaves at the Operation Warp Speed Vaccine Summit in Washington on Dec. 8, 2020. (Tasos Katopodis/Getty Images)

MaryJo Perry, a longtime advocate for vaccine choice and a Trump supporter, thinks votes will be at a premium come Election Day, particularly because the independent and third-party field is becoming more competitive.

Ms. Perry, president of Mississippi Parents for Vaccine Rights, believes advocates for medical freedom could determine who is ultimately president.

She believes that Mr. Kennedy is “pulling votes from Trump” because of the former president’s stance on the vaccines.

“People care about medical freedom. It’s an important issue here in Mississippi, and across the country,” Ms. Perry told The Epoch Times.

“Trump should admit he was wrong about Operation Warp Speed and that COVID vaccines have been dangerous. That would make a difference among people he has offended.”

President Trump won’t lose enough votes to Mr. Kennedy about Operation Warp Speed and COVID vaccines to have a significant impact on the election, Ohio Republican strategist Wes Farno told The Epoch Times.

President Trump won in Ohio by eight percentage points in both 2016 and 2020. The Ohio Republican Party endorsed President Trump for the nomination in 2024.

“The positives of a Trump presidency far outweigh the negatives,” Mr. Farno said. “People are more concerned about their wallet and the economy.

“They are asking themselves if they were better off during President Trump’s term compared to since President Biden took office. The answer to that question is obvious because many Americans are struggling to afford groceries, gas, mortgages, and rent payments.

“America needs President Trump.”

Multiple national polls back Mr. Farno’s view.

As of March 6, the RealClearPolitics average of polls indicates that President Trump has 41.8 percent support in a five-way race that includes President Biden (38.4 percent), Mr. Kennedy (12.7 percent), independent Cornel West (2.6 percent), and Green Party nominee Jill Stein (1.7 percent).

A Pew Research Center study conducted among 10,133 U.S. adults from Feb. 7 to Feb. 11 showed that Democrats and Democrat-leaning independents (42 percent) are more likely than Republicans and GOP-leaning independents (15 percent) to say they have received an updated COVID vaccine.

The poll also reported that just 28 percent of adults say they have received the updated COVID inoculation.

The peer-reviewed multinational study of more than 99 million vaccinated people that Mr. Kennedy referenced in his X post on March 7 was published in the Vaccine journal on Feb. 12.

It aimed to evaluate the risk of 13 adverse events of special interest (AESI) following COVID-19 vaccination. The AESIs spanned three categories—neurological, hematologic (blood), and cardiovascular.

The study reviewed data collected from more than 99 million vaccinated people from eight nations—Argentina, Australia, Canada, Denmark, Finland, France, New Zealand, and Scotland—looking at risks up to 42 days after getting the shots.

Three vaccines—Pfizer and Moderna’s mRNA vaccines as well as AstraZeneca’s viral vector jab—were examined in the study.

Researchers found higher-than-expected cases that they deemed met the threshold to be potential safety signals for multiple AESIs, including for Guillain-Barre syndrome (GBS), cerebral venous sinus thrombosis (CVST), myocarditis, and pericarditis.

A safety signal refers to information that could suggest a potential risk or harm that may be associated with a medical product.

The study identified higher incidences of neurological, cardiovascular, and blood disorder complications than what the researchers expected.

President Trump’s role in Operation Warp Speed, and his continued praise of the COVID vaccine, remains a concern for some voters, including those who still support him.

Krista Cobb is a 40-year-old mother in western Ohio. She voted for President Trump in 2020 and said she would cast her vote for him this November, but she was stunned when she saw his response to President Biden about the COVID-19 vaccine during the State of the Union address.

“I love President Trump and support his policies, but at this point, he has to know they [advisers and health officials] lied about the shot,” Ms. Cobb told The Epoch Times.

“If he continues to promote it, especially after all of the hearings they’ve had about it in Congress, the side effects, and cover-ups on Capitol Hill, at what point does he become the same as the people who have lied?” Ms. Cobb added.

“I think he should distance himself from talk about Operation Warp Speed and even admit that he was wrong—that the vaccines have not had the impact he was told they would have. If he did that, people would respect him even more.”

Tyler Durden Mon, 03/11/2024 - 17:00

Read More

Continue Reading

Spread & Containment

The next pandemic? It’s already here for Earth’s wildlife

Bird flu is decimating species already threatened by climate change and habitat loss.

Published

8 hours ago

on

March 11, 2024

By

I am a conservation biologist who studies emerging infectious diseases. When people ask me what I think the next pandemic will be I often say that we are in the midst of one – it’s just afflicting a great many species more than ours.

I am referring to the highly pathogenic strain of avian influenza H5N1 (HPAI H5N1), otherwise known as bird flu, which has killed millions of birds and unknown numbers of mammals, particularly during the past three years.

This is the strain that emerged in domestic geese in China in 1997 and quickly jumped to humans in south-east Asia with a mortality rate of around 40-50%. My research group encountered the virus when it killed a mammal, an endangered Owston’s palm civet, in a captive breeding programme in Cuc Phuong National Park Vietnam in 2005.

How these animals caught bird flu was never confirmed. Their diet is mainly earthworms, so they had not been infected by eating diseased poultry like many captive tigers in the region.

This discovery prompted us to collate all confirmed reports of fatal infection with bird flu to assess just how broad a threat to wildlife this virus might pose.

This is how a newly discovered virus in Chinese poultry came to threaten so much of the world’s biodiversity.

H5N1 originated on a Chinese poultry farm in 1997. ChameleonsEye/Shutterstock

The first signs

Until December 2005, most confirmed infections had been found in a few zoos and rescue centres in Thailand and Cambodia. Our analysis in 2006 showed that nearly half (48%) of all the different groups of birds (known to taxonomists as “orders”) contained a species in which a fatal infection of bird flu had been reported. These 13 orders comprised 84% of all bird species.

We reasoned 20 years ago that the strains of H5N1 circulating were probably highly pathogenic to all bird orders. We also showed that the list of confirmed infected species included those that were globally threatened and that important habitats, such as Vietnam’s Mekong delta, lay close to reported poultry outbreaks.

Mammals known to be susceptible to bird flu during the early 2000s included primates, rodents, pigs and rabbits. Large carnivores such as Bengal tigers and clouded leopards were reported to have been killed, as well as domestic cats.

Our 2006 paper showed the ease with which this virus crossed species barriers and suggested it might one day produce a pandemic-scale threat to global biodiversity.

Unfortunately, our warnings were correct.

A roving sickness

Two decades on, bird flu is killing species from the high Arctic to mainland Antarctica.

In the past couple of years, bird flu has spread rapidly across Europe and infiltrated North and South America, killing millions of poultry and a variety of bird and mammal species. A recent paper found that 26 countries have reported at least 48 mammal species that have died from the virus since 2020, when the latest increase in reported infections started.

Not even the ocean is safe. Since 2020, 13 species of aquatic mammal have succumbed, including American sea lions, porpoises and dolphins, often dying in their thousands in South America. A wide range of scavenging and predatory mammals that live on land are now also confirmed to be susceptible, including mountain lions, lynx, brown, black and polar bears.

The UK alone has lost over 75% of its great skuas and seen a 25% decline in northern gannets. Recent declines in sandwich terns (35%) and common terns (42%) were also largely driven by the virus.

Scientists haven’t managed to completely sequence the virus in all affected species. Research and continuous surveillance could tell us how adaptable it ultimately becomes, and whether it can jump to even more species. We know it can already infect humans – one or more genetic mutations may make it more infectious.

At the crossroads

Between January 1 2003 and December 21 2023, 882 cases of human infection with the H5N1 virus were reported from 23 countries, of which 461 (52%) were fatal.

Of these fatal cases, more than half were in Vietnam, China, Cambodia and Laos. Poultry-to-human infections were first recorded in Cambodia in December 2003. Intermittent cases were reported until 2014, followed by a gap until 2023, yielding 41 deaths from 64 cases. The subtype of H5N1 virus responsible has been detected in poultry in Cambodia since 2014. In the early 2000s, the H5N1 virus circulating had a high human mortality rate, so it is worrying that we are now starting to see people dying after contact with poultry again.

It’s not just H5 subtypes of bird flu that concern humans. The H10N1 virus was originally isolated from wild birds in South Korea, but has also been reported in samples from China and Mongolia.

Recent research found that these particular virus subtypes may be able to jump to humans after they were found to be pathogenic in laboratory mice and ferrets. The first person who was confirmed to be infected with H10N5 died in China on January 27 2024, but this patient was also suffering from seasonal flu (H3N2). They had been exposed to live poultry which also tested positive for H10N5.

Species already threatened with extinction are among those which have died due to bird flu in the past three years. The first deaths from the virus in mainland Antarctica have just been confirmed in skuas, highlighting a looming threat to penguin colonies whose eggs and chicks skuas prey on. Humboldt penguins have already been killed by the virus in Chile.

A colony of king penguins.
Remote penguin colonies are already threatened by climate change. AndreAnita/Shutterstock

How can we stem this tsunami of H5N1 and other avian influenzas? Completely overhaul poultry production on a global scale. Make farms self-sufficient in rearing eggs and chicks instead of exporting them internationally. The trend towards megafarms containing over a million birds must be stopped in its tracks.

To prevent the worst outcomes for this virus, we must revisit its primary source: the incubator of intensive poultry farms.

Diana Bell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

Trending